Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...

CAPLYTA net product sales grew to $199.2 million, representing a 51%increase over the same period in 2023Full year 2024 ...

Thailand’s Food and Drug Administration (FDA) has revised the criteria for beverages, seasonings, packaged soup bases and ...

Chances are, you know someone with Alzheimer's disease or a related dementia involving memory loss. That's due in part to the fact that as our older population grows, so does the number of people ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration ... and no new safety risks were ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato ... using one antidepressant medication, and 50% have no response with just one drug. “Over the past 20 years ...

South Korea food labels, Indonesia GM food hoaxes, China food safety concerns and more feature in this edition of Safety First.